Skip to main content

Day: March 24, 2022

Vaxxinity Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Updates

DALLAS, March 24, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2021. “2021 was a transformational year for Vaxxinity as we completed an initial public offering and bolstered our clinical research and management teams in pursuit of our mission to disrupt the existing antibody therapy paradigm and democratize health,” said Mei Mei Hu, CEO of Vaxxinity. “In the next 12 months we expect to demonstrate our strength of execution by meaningfully advancing multiple pipeline programs through and into the clinic. We look forward to key topline readouts including UB-312 Phase 1 in Parkinson’s patients, UB-612 Phase 3 as a heterologous boost against Covid-19,...

Continue reading

AutoWeb Reports Fourth Quarter and Full Year 2021 Results

– 2021 Marked Continued Progress with Transformation Strategy Amidst Challenging Macro-Economic Conditions – – Efforts to Scale Vehicle Acquisition Business in 2022 Remains a Priority – TAMPA, Fla., March 24, 2022 (GLOBE NEWSWIRE) — AutoWeb, Inc. (Nasdaq: AUTO), an automotive matchmaking platform connecting in-market car shoppers to their preferred vehicle transactions, is reporting financial results for the fourth quarter and full year ended December 31, 2021. “2021 marked another year of progress for our transformation strategy, despite operating against unfavorable macro-economic conditions throughout the year,” said Jared Rowe, president and CEO of AutoWeb. “Although headwinds from supply challenges across the automotive industry persisted as we closed out the year, we continued to make meaningful strides...

Continue reading

Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights

HighlightsPhase 1 IMMUNICY-1 trial demonstrated encouraging data to date for CYAD-211 including a good tolerability profile and evidence of clinical activity in relapsed/refractory multiple myeloma (r/r MM) patients Investigation ongoing of findings in CYAD-101-002 Phase 1b trial following announcement of clinical hold by FDA Cash position of €30.0 million ($34.0 million) as of December 31, 2021 Conference call and webcast scheduled for March 25 at 1:00 p.m. CET / 8:00 a.m. EDTMONT-SAINT-GUIBERT, Belgium, March 24, 2022 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced its financial results for the fiscal year 2021 ended December...

Continue reading

Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 71st Annual Scientific Session & Expo

SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four presentations at the American College of Cardiology 71st Annual Scientific Session & Expo (ACC.22) taking place in Washington, D.C. from April 2, 2022 – April 4, 2022. The presentations will include the full results from METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related to Increased Contractility in Heart Failure), a Phase 3 clinical trial omecamtiv mecarbil in patients with heart failure with reduced ejection fraction, in a Late Breaking Clinical Trial Session, as well as the results from Cohort 3 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), the Phase 2 clinical trial of aficamten in patients with hypertrophic...

Continue reading

RENAULT GROUP: Availability of the 2021 Universal Registration Document

PRESS RELEASE March 24, 2022Availability of the 2021 Universal Registration Document Boulogne-Billancourt, March 24, 2022 – Renault announces that the 2021 Universal Registration Document (in French version) has been filed, in ESEF format, with the French Financial Markets Authority (Autorité des Marchés Financiers – AMF), on March 24, 2022. The 2021 Universal Registration Document (French version) is available on Renault Group’s website www.grouprenault.com, under “Finance/ Information réglementée”. The English version will be available soon at the following address: https://www.renaultgroup.com/en/finance-2/regulated-information/ The Universal Registration Document includes in particular the Annual Financial Report, the Corporate Governance Report, the statutory auditors’ reports and their fees, as well as the information...

Continue reading

FIRST URANIUM RESOURCES LTD. ANNOUNCES UPSIZE PRIVATE PLACEMENT FINANCING TO $8M

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — First Uranium Resources Ltd. (the “Company” or “First Uranium”) (CSE: URNM) (OTCPK: KMMIF) (FSE:5KA0) is pleased to announce it has increased the size of the previously announced financing to C$8,000,000. The Company will issue subscription receipts of up to $8,000,000 gross proceeds at a price of $0.35 per subscription receipt for a total of up to 22,857,150 subscription receipts. Each subscription receipt is convertible into one common share and one half of a share purchase warrant, each whole warrant being exercisable into a common share for a price of $0.50 per share. The proceeds of the subscription private placement will be utilized for exploration work, and acquisition...

Continue reading

Notice of Flow Capital’s 2021 Annual Financial Results Conference Call

Financial results to be released after markets on Thursday, March 31, 2022 TORONTO, Ontario,, March 24, 2022 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital” and “Company”) today announced it will release its 2021 annual financial results after the markets close on Thursday, March 31, 2022. Mr. Alex Baluta, Chief Executive Officer, and Mr. Gaurav Singh, Chief Financial Officer, will host a conference call at 9:00 a.m. ET, on Friday, April 1, 2022, to review the results. A question and answer session will follow the corporate update. CONFERENCE CALL DETAILS DATE:        Friday, April 1, 2022 TIME:        9:00 AM Eastern Time DIAL IN NUMBER:        +1 833 968-1926 or +1 778 560-2703 TAPED REPLAY:        +1 800 585-8367 or +1 416 621-4642 CONFERENCE ID:        1143478 A recording of the call will be archived on the...

Continue reading

Velocity Announces New Director

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Velocity Minerals Ltd. (TSX.V: VLC) (“Velocity” or the “Company”) announces the appointment of Chris Batalha to its board of directors (the “Board”), as the nominee of Artemis Gold Inc. under the January 16, 2019 strategic investment agreement between the parties, replacing Steven Dean. Mr. Dean has resigned as a director of Velocity effective March 23, 2022, but will remain an advisor to the Board. Chris Batalha Chris Batalha is a Certified Professional Accountant with over a decade of experience in accounting, finance, corporate governance, tax, budgeting and M&A with a number of mining exploration and development companies in the gold and iron ore space. Currently, Mr. Batalha is the CFO of Artemis Gold Inc., owner of the Blackwater Gold Project in Central British...

Continue reading

Proactive news headlines including Nevada Silver, Contakt World, SPYR Technologies, Gamesquare Esports, Bloom Health Partners and Predictive Oncology

New York , March 24, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Nevada Silver provides update on Emily Manganese project and Belmont silver property purchase click here Contakt World announces name change to Infinity Stone Ventures Corp  click here Belmont Resources and JV partner Marquee Resources hire contractor to drill Kibby Basin lithium project in Nevada  click here SPYR Technologies says subsidiary introduces limited-time special pricing for MagixDrive, expands airing schedule of national commercial  click here Klondike Gold hits multi-ounce silver intersection in Phase 4 diamond drilling at its flagship Yukon project  click here Harbor Custom Development reports strong top-line revenue growth in...

Continue reading

Deep Down, Inc. Announces Timing of Year-End 2021 Earnings Release and Conference Call

HOUSTON, March 24, 2022 (GLOBE NEWSWIRE) — Deep Down, Inc. (OTCQB: DPDW), a specialist in deepwater energy production and distribution equipment and services, announced today that it will host an investor conference call to review its full-year 2021 results on Tuesday, March 29, 2022 at 10:00 am Eastern Time (details below). Deep Down will release its full-year 2021 results on Monday, March 28, 2022 following the market close.Call Dial-in: Toll Free: 1-877-303-6187  Toll/International: 1-678-894-3073  Passcode: 7377886Webcast URL: https://edge.media-server.com/mmc/p/xwtajgxu A replay will be available through March 26, 2021 on our website, www.koilenergy.com, under the “Investors” section. About Deep Down, Inc. (www.deepdowninc.com) Deep Down is a leading energy services company offering subsea equipment and support...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.